Stock & Company Details
Dermata Therapeutics Inc $DRMA
Price:
N/A
N/A
5M
$4.3M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.15
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DRMA technical indicators
Latest Dermata Therapeutics Inc (DRMA) indicator readings as of 2026-10-29.
DRMA's 14-day RSI is 43.3, in neutral territory. At $0.84 it is trading 36.4% below its 200-day moving average of $1.32, and below its 50-day average of $1.12. Price sits in the middle of its Bollinger Bands ($0.63 to $1.18). ADX reads 18.1, indicating a range-bound market rather than a trend.
Overview
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Finance Bot
Ask your questions
Start by typing a question below.
